Document is current
Any future updates will be listed below
-
Authors
Addington, Jean https://orcid.org/0000-0002-8298-0756
Liu, Lu
Braun, Amy
Auther, Andrea
Calkins, Monica E.
Cornblatt, Barbara A.
Corcoran, Cheryl M. https://orcid.org/0000-0002-8902-4353
Fusar-Poli, Paolo
Kerr, Melissa J.
Mourgues-Codern, Catalina V.
Nunez, Angela R.
Oliver, Dominic https://orcid.org/0000-0002-8920-3407
Strauss, Gregory P.
Walsh, Barbara C.
Alameda, Luis K. https://orcid.org/0000-0002-8621-2885
Arango, Celso https://orcid.org/0000-0003-3382-4754
Breitborde, Nicholas J. K.
Broome, Matthew R. https://orcid.org/0000-0002-6963-8884
Cadenhead, Kristin S. https://orcid.org/0000-0002-5952-4605
Carrion, Ricardo E. https://orcid.org/0000-0002-6393-392X
Chen, Eric Yu Hai https://orcid.org/0000-0002-5247-3593
Choi, Jimmy
Coleman, Michael J.
Conus, Philippe
Diaz-Caneja, Covadonga M. https://orcid.org/0000-0001-8538-3175
Dwyer, Dominic https://orcid.org/0000-0003-3949-5867
Ellman, Lauren M.
Faghankhani, Masoomeh https://orcid.org/0000-0003-0734-5047
Gaspar, Pablo A. https://orcid.org/0000-0002-9682-5327
Gerber, Carla
Glenthøj, Louise Birkedal
Horton, Leslie E.
Hui, Christy
Jacobs, Grace R. https://orcid.org/0000-0001-9961-6507
Kambeitz, Joseph https://orcid.org/0000-0002-8988-3959
Kambeitz-Ilankovic, Lana
Keshavan, Matcheri S.
Kim, Sung-Wan https://orcid.org/0000-0002-6739-2163
Koutsouleris, Nikolaos https://orcid.org/0000-0001-6825-6262
Kwon, Jun Soo https://orcid.org/0000-0002-1060-1462
Langbein, Kerstin
Lewandowski, Kathryn E. https://orcid.org/0000-0003-1477-6187
Mamah, Daniel
Marcy, Patricia J.
Mathalon, Daniel H.
Mittal, Vijay A. https://orcid.org/0000-0001-9017-5119
Nordentoft, Merete
Pearlson, Godfrey D.
Penzel, Nora https://orcid.org/0000-0003-1624-386X
Perez, Jesus
Perkins, Diana O. https://orcid.org/0000-0001-9396-2206
Powers, Albert R. III https://orcid.org/0000-0003-3057-5043
Rogers, Jack
Sabb, Fred W.
Schiffman, Jason
Shah, Jai L. https://orcid.org/0000-0002-7549-6990
Silverstein, Steven M. https://orcid.org/0000-0002-0699-0960
Smesny, Stefan
Stone, William S.
Thompson, Andrew
Thompson, Judy L.
Upthegrove, Rachel https://orcid.org/0000-0001-8204-5103
Verma, Swapna
Wang, Jijun https://orcid.org/0000-0001-5427-7425
Wastler, Heather M.
Wickham, Alana
Rossum, Inge Winter-van
Wolf, Daniel H. https://orcid.org/0000-0002-9731-8781
Bouix, Sylvain https://orcid.org/0000-0003-1326-6054
Pasternak, Ofer
Kahn, Rene S. https://orcid.org/0000-0001-5909-8004
Bearden, Carrie E. https://orcid.org/0000-0002-8516-923X
Kane, John M.
McGorry, Patrick D.
Buccilli, Kate
Nelson, Barnaby
Shenton, Martha E. https://orcid.org/0000-0003-4235-7879
Woods, Scott W. https://orcid.org/0000-0002-3103-5228
,
Yung, Alison R. https://orcid.org/0000-0002-0401-9791
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH124639)
- License Information
-
More Information
Article History
Received: 4 September 2024
Accepted: 4 December 2024
First Online: 3 April 2025
Competing interests
: Dr A. Thomson has received honorarium and/or grants from Ostuka, Boehringer, Eli Lilly, Janssen Cilag, Lundbeck, Pfizer and Sunovion. Dr C. Arango has been a consultant to and/or has received honorarium and or grants from Acadia, Angelini, Biogen, Boehringer, Gideon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Shering Plough, Sumitomo Dainippon Pharma, Sunovian and Takeda. Dr R. Upthegrove has received speaker fees for Otsuka and consulted to Viatris and Springer Healthcare. Dr P. Fusar-Poli has received research funds or personal fees from Angelini, Boehringer, Lundbeck, Menarini, Otsuka, Sunovian and Poxymm Science. Dr. S. Woods has received speaking fees from the American Psychiatric Association and from Medscape Features. He has been granted US patent no. 8492418 B2 for a method of treating prodromal schizophrenia with glycine agonists. He owns stock in NW PharmaTech. Dr C Diaz-Caneja has received grant support from Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation and honoraria or travel support from Angelini, Janssen, and Viatris. Dr Dwyer has received honorary funds for one educational seminar for CSL Sequiris. Dr. Kambeitz has received speaking or consulting fees from Janssen, Boehringer Ingelheim, ROVI and Lundbeck. Patricia J. Marcy is a consultant for Otsuka and TEVA. Dr R S. Kahn is a consultant for Alkermes, Boehringer-Ingelheim. Dr. M. KaneConsultant to or receives honoraria and/or travel support and/or speakers bureau: Alkermes, Allergan, Boehringer-Ingelheim, Cerevel, Dainippon Sumitomo, H. Lundbeck, HealthRhythms, HLS Therapeutics, Indivior, Intracellular Therapies, Janssen Pharmaceutical, Johnson & Johnson, Karuna Therapeutics/Bristol Meyer-Squibb, LB Pharmaceuticals, Mapi, Maplight, Merck, Minerva, Neurocrine, Newron, Novartis, NW PharmaTech, Otsuka, Roche, Saladax, Sunovion, Teva Advisory Boards: Alkermes, Boehringer-Ingelheim, Cerevel, Click Therapeutics, Karuna/BMS, Lundbeck, Merck, Newron, Novartis, Otsuka, Sumitomo, Teva, Terran Grant Support: Lundbeck, Janssen, Otsuka, Sunovion and has Shareholder interests in Cerevel (public/stock), HealthRhythms (private/stock options), Karuna/BMS (public), LB Pharmaceuticals, Inc. (private/stock options), North Shore Therapeutics (private/stock), Vanguard Research Group (private/40% owner). All other authors report no competing interests.
